Gateway to Think Tanks
来源类型 | Working Paper |
规范类型 | 报告 |
DOI | 10.3386/w23257 |
来源ID | Working Paper 23257 |
The Impact of Information Technology on the Diffusion of New Pharmaceuticals | |
Kenneth J. Arrow; Kamran Bilir; Alan T. Sorensen | |
发表日期 | 2017-03-20 |
出版年 | 2017 |
语种 | 英语 |
摘要 | Do information differences across U.S. physicians contribute to treatment disparities? This paper uses a unique new dataset to evaluate how changes in physician access to a decision-relevant drug database affect prescribing decisions. Our results indicate that doctors using the reference have a significantly greater propensity to prescribe generic drugs, are faster to begin prescribing new generics, and prescribe a more diverse set of products. Notably, physicians using the reference database are not faster to prescribe new branded drugs. Given that a new generic drug resembles its branded equivalent clinically, these results are consistent with database users responding primarily to the increased accessibility of non-clinical information such as drug price and insurance formulary data; the results also suggest improvements to physician information access have important aggregate implications for the costs and efficiency of medical care. We address possible selection effects in physician types by relying on within-doctor variation and an instrument for adoption timing that is based on the marketing strategy of the drug reference firm. |
主题 | Health, Education, and Welfare ; Health ; Development and Growth ; Innovation and R& ; D |
URL | https://www.nber.org/papers/w23257 |
来源智库 | National Bureau of Economic Research (United States) |
引用统计 | |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/580931 |
推荐引用方式 GB/T 7714 | Kenneth J. Arrow,Kamran Bilir,Alan T. Sorensen. The Impact of Information Technology on the Diffusion of New Pharmaceuticals. 2017. |
条目包含的文件 | ||||||
文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
w23257.pdf(1188KB) | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。